Oral Insulin
Links shared publicly online about this topic
Biolaxy Secures IND Approval For Oral Insulin
medicalnewstoday.com — “Shanghai biolaxy announced the chinese state food & drug administration (sfda) has approved the investigational new drug application (ind) for its oral insulin project (nodlin), an innovative insu” View full resource at medicalnewstoday.com
Most Recently Shared on November 25, 2009 at 2:15 pm By:
Biolaxy Secures IND Approval For Oral Insulin: Shanghai Biolaxy announced the Chinese State Food & Drug Adminis.. http://bit.ly/7Vt5jP
Novo Nordisk makes progress with oral insulin | Reuters
reuters.com — “NEW YORK (Reuters) - Danish drugmaker Novo Nordisk , the world's biggest insulin maker, said on Wednesday it is making progress in developing a tablet form of the drug -- a holy grail of” View full resource at reuters.com
Most Recently Shared on November 11, 2009 at 7:09 pm By:
RT @diabetescure: Novo Nordisk makes progress with oral insulin: Diabetics who need insulin, a naturally occurring... http://bit.ly/47UcR4
Novo to develop oral insulin | InPharm
inpharm.com — “InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company listings.” View full resource at inpharm.com
Most Recently Shared on December 22, 2010 at 11:20 am By:
Pharmafocus Health News and Pharma
Novo to develop oral insulin http://goo.gl/fb/J3Z79
Oral Insulin Spray (Generex Oral-lyn) - TuDiabetes
tudiabetes.org — “Wonder if this oral delivery method has less preservatives than injected insulin. It would be an answer to absorption issues & scar tissue problems. Not so good for those who need insulin to last longer. Interesting. From www.diabetesincontrol.com: Update on Generex Oral-lyn An independent review of clinical trials of Generex Oral-lyn(TM) shows that the oral insulin spray has a faster onset of action and shorter duration of action than insulin delivered subcutaneously. The ease of u” View full resource at tudiabetes.org
Most Recently Shared on December 13, 2009 at 3:50 pm By:
Type 1 diabetes: Oral Insulin Spray (Generex Oral-lyn): Wonder if this oral delivery method has less preservatives ... http://bit.ly/90hJ3h
Insulin in a Capsule: The Promising Development of Oral Insulin | A Sweet Life
asweetlife.org — “Oramed's oral insulin for the treatment of diabetes has shown good results in early trials and apparently doesn't cause hypoglycemia.” View full resource at asweetlife.org
Most Recently Shared on January 24, 2012 at 2:58 pm By:
jessica apple Health Communicator and Patient Expert
Wouldn't it be great to swallow your insulin? My piece on the development of oral insulin for #diabetes http://t.co/K698ng3g
Long-Term Outcome of Individuals Treated With Oral Insulin
care.diabetesjournals.org — “Long-Term Outcome of Individuals Treated With Oral Insulin” View full resource at care.diabetesjournals.org
Most Recently Shared on May 25, 2011 at 7:09 pm By:
Long-Term Outcome of Individuals Treated With Oral Insulin (Diabetes Care) http://bit.ly/ksdhe1
children with DIABETES - TrialNet Oral Insulin Trial
childrenwithdiabetes.com — “Children with Diabetes is the online community for parents, kids, adults, and families living with type 1 diabetes.” View full resource at childrenwithdiabetes.com
Most Recently Shared on April 14, 2011 at 1:48 am By:
TrialNet Oral Insulin Trial chat with Dr. Bruce Buckingham transcript on CWD from April 12, 2011 http://bit.ly/fRLGLN #diabetes
Oral Insulin Conditionally Approved by FDA :: Diabetes Self-Management
diabetesselfmanagement.com — “The u.s. food and drug administration (fda) has approved oral-lyn, an insulin spray for people with type 1 and type 2 diabetes, for its treatment investigational new drug (ind) program. this approval will allow generex biotechnology corporation, developers of oral-lyn, to provide early access to the medicine to people with serious or life-threatening type 1 or type 2 diabetes who have no satisfactory alternative treatments and who are not eligible for participation in the company's ongoing phase” View full resource at diabetesselfmanagement.com
Most Recently Shared on September 18, 2009 at 7:57 pm By:
Diabetes Self-Mgmt Health Site
#diabetes An innovative insulin product was recently approved for certain people with diabetes. http://bit.ly/1atbiw
Access Pharmaceuticals Signs Agreement With Major Global Pharmaceutical Company For Its CobOral™ Oral Insulin Formulation
medicalnewstoday.com — “ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportiv” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2010 at 4:07 pm By:
Access Pharmaceuticals Signs Agreement With Major Global Pharmaceutical Company For Its CobOralâ„¢ Oral Insulin Formulati.. http://dld.bz/Aded
Access Pharmaceuticals Reports Significant Oral Bioavailability Of Cobalamin(TM) Oral Insulin In Additional Studies
medicalnewstoday.com — “ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that it has received reports of significant bioavailability of orally delivered insulin in two independently-conducted animal stud” View full resource at medicalnewstoday.com
Most Recently Shared on March 12, 2010 at 2:08 pm By:
Scott Strumello Patient Expert
Access Pharmaceuticals Reports Significant Oral Bioavailability of Cobalamin Oral Insulin In Additional Studies: http://bit.ly/dbxBDT
PharmaLive: Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Oramed's Oral Insulin Capsules
pharmalive.com — “PharmaLive: Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Oramed's Oral Insulin Capsules” View full resource at pharmalive.com
Most Recently Shared on July 7, 2010 at 7:58 pm By:
Oramed Pharma & sanofi-aventis Enter Into Agreement 4 Insulin Supply of Oramed's Oral Insulin Capsules http://tinyurl.com/2g8n4ep #diabetes
Oramed to present data on oral insulin formulation for Type II diabetes at Annual Meeting in Bethesda
news-medical.net — “Oramed Pharmaceuticals Inc. a developer of oral drug delivery systems, announced today that its work entitled "Extended exposure to an oral insulin formulation yields decreased insulin secretion in Type II diabetes subjects," will be presented at the Tenth Annual Meeting of the Diabetes Technology Society, to be held in Bethesda, Maryland this November.” View full resource at news-medical.net
Most Recently Shared on October 27, 2010 at 5:40 am By:
Oramed to present data on oral insulin formulation for Type II diabetes at Annual Meeting in Bethesda: Oramed Phar... http://bit.ly/aVJAQA
Oramed Pharmaceuticals Announces Successful Results Of A Novel Exploratory Clinical Study Of Its Flagship Oral Insulin Capsule
medicalnewstoday.com — “Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced successful results in an exploratory clinical trial testing the effectiveness of its oral insulin capsule (ORMD-0801) in Type I diabetes pati” View full resource at medicalnewstoday.com
Most Recently Shared on September 15, 2010 at 3:00 pm By:
Oramed Pharmaceuticals Announces Successful Results Of A Novel Exploratory Clinical Study Of Its Flagship Oral Insulin... http://mnt.to/3JM8
Oramed Pharmaceuticals To Present Results Of An Oral Insulin Administration Study At The Tenth Annual Meeting Of The Diabetes Technology Society
medicalnewstoday.com — “Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of oral drug delivery systems, announced today that its work entitled Extended exposure to an oral insulin formulation yields decreased i” View full resource at medicalnewstoday.com
Most Recently Shared on October 27, 2010 at 12:44 pm By:
Scott Strumello Patient Expert
Oramed Pharmaceuticals to Present Results of Oral Insulin Admin Study @ 10th Annual Mtg of Diabetes Tech Soc: http://bit.ly/aBi9t8
OssulinTM, A Novel Oral Insulin Product, Shows Promising Bioavailability For Advancing Diabetes Therapy
medicalnewstoday.com — “New data from puredel limited, presented at the 9th annual diabetes technology meeting in san francisco, ca, suggests that higher blood levels of insulin were achieved by ossulin™ than had b” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2009 at 12:51 pm By:
OssulinTM, A Novel Oral Insulin Product, Shows Promising Bioavailability For Advancing Diabetes Therapy: New da.. http://bit.ly/1oC6EK
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT Diabetes News
The latest diabetes news published daily. Articles from research centers, universities and prestigious journals.
-
HCPLive
Your online destination for Endocrinology news,events, and resources
-
Pharmafocus
Monthly pharmaceutical, biotech & healthcare news publication for Europe. For pharma & biotech jobs follow @inpharmjobs. Twitter accounts run by @dominic_tyer
Advertisement
